Purdue Pharma reaches $8.3 billion deal with DOJ
STAMFORD, Conn. – Purdue Pharma announced Wednesday that it has entered into an $8.3 billion agreement with the United States Department of Justice (DOJ) to resolve multi-year civil and criminal investigations into the company’s past marketing practices related to its opioid medicines. With the agreement, Purdue accepts responsibility for specified misconduct that took place before